登录    
  
首页 > 期刊论文 > 论文摘要
晚期糖基化终产物受体异常表达对肿瘤发生和侵袭转移的影响
         
Role of abnormal expression of receptor for advanced glycosylation end products in carcinogenesis, tumor invasion, and metastasis

摘    要
以往人们将晚期糖基化终产物受体(receptor for advanced glycosylation end products,RAGE)的研究重点放在糖尿病血管病变中。近年来的临床研究发现,RAGE在人肝癌、胃癌、胰腺癌和前列腺癌等多种肿瘤组织中均高表达,而在横纹肌肉瘤和肺癌组织中低表达。RAGE的异常表达与肿瘤的发生、血管生成和侵袭转移等恶性化程度密切相关。本文对不同肿瘤组织中RAGE的异常表达及其与肿瘤发生、发展的相关性进行简要综述。
标    签 肿瘤   基因表达   肿瘤转移   晚期糖基化终产物受体   Neoplasms   Gene expression   Neoplasm metastasis   Receptor for advanced glycosylation end products  
 
Abstract
Receptor for advanced glycosylation end products(RAGE) has long been a focus in studies of diabetic vascular diseases.Recently,clinical evidence has shown that the expression level of RAGE is high in liver,stomach,pancreas and prostate cancer tissues whereas the expression level of RAGE is lower in chondrosarcoma and lung cancer tissues.The abnormal expression of RAGE is closely associated with tumorgenesis,angiogenesis,tumor invasion and metastasis.This review summarizes the abnormal expression of RAGE in different tumors and its role in carcinogenesis and development of tumor.

中图分类号 R730.2   DOI 10.3781/j.issn.1000-7431.2011.10.015

 
  购买该论文  中国光学期刊网论文下载说明
      


所属栏目 综述

基金项目

收稿日期 2011/5/3

修改稿日期 2011/7/4

网络出版日期

作者单位点击查看


引用该论文: YUE Zhi-qiang,WANG Ying-yu,LIU Yu-ping,ZHENG Shi-zhong,LU Yin. Role of abnormal expression of receptor for advanced glycosylation end products in carcinogenesis, tumor invasion, and metastasis[J]. Tumor, 2011, 31(10): 957~960
岳志强,王颖钰,刘玉萍,郑仕中,陆茵. 晚期糖基化终产物受体异常表达对肿瘤发生和侵袭转移的影响[J]. 肿瘤, 2011, 31(10): 957~960


论文评价
共有人对该论文发表了看法,其中:
人认为该论文很差
人认为该论文较差
人认为该论文一般
人认为该论文较好
人认为该论文很好
分享论文
分享到新浪微博 分享到腾讯微博 分享到人人网 分享到 Google Reader 分享到百度搜藏分享到Twitter

参考文献
【1】HUDSO B I, CARTER A M, HARJA E, et al. Identification, classification, and expression of RAGE gene splice variants[J]. FASEB J, 2008, 22(5):1572-1580.
 
【2】KOCH M, CHITAYAT S, DATTILO B M, et al. Structural basis for ligand recognition and activation of RAGE[J]. Structure, 2010, 18(10):1342-1352.
 
【3】YAN S F, RAMASAMY R, SCHMIDT A M. Mechanisms of disease:advanced glycation end-products and their receptor in inflammation and diabetes complications[J]. Nat Clin Pract Endocrinol Metab, 2008, 4(5):285-293.
 
【4】ALEXIOU P, CHATZOPOULOU M, PEGKLIDOU K, et al. RAGE:a multi-ligand receptor unveiling novel insights in health and disease[J]. Curr Med Chem, 2010, 17(21):2232-2252.
 
【5】PIETKIEWICZ J, SEWERYN E, BARTYS A, et al. Receptors for advanced glycation end products and their physiological and clinical significance[J]. Postepy Hig Med Dosw, 2008, 62:511-523.
 
【6】MOSQUERA J A. Role of the receptor for advanced glycation end products (RAGE) in inflammation[J]. Invest Clin, 2010, 51(2):257-268.
 
【7】YAMAGISHI S, NAKAMURA K, MATSUI T, et al. Receptor for advanced glycation end products (RAGE):a novel therapeutic target for diabetic vascular complication[J]. Curr Pharm Des, 2008, 14(5):487-495.
 
【8】REINIGER N, LAU K, McCALLA D, et al. Deletion of the receptor for advanced glycation end products reduces glomerulosclerosis and preserves renal function in the diabetic OVE26 mouse[J]. Diabetes, 2010, 59(8):2043-2054.
 
【9】GEBHARDT C, RIEHL A, DURCHDEWALD M, et al. RAGE signaling sustains inflammation and promotes tumor development[J]. J Exp Med, 2008, 205(2):275-285.
 
【10】TAGUCHI A, BLOOD D C, DEL TORO G, et al. Blockade of RAGE-amphoterin signaling suppresses tumour growth and metastases[J]. Nature, 2000, 405(6784):354-360.
 
【11】HIWAYASHI K, UENO S, ABEYAMA K, et al. A novel function of the receptor for advanced glycation end-products (RAGE) in association with tumorigenesis and tumor differentiation of HCC[J]. Ann Surg Oncol, 2008, 15(3):923-933.
 
【12】JING R R, WANG H M, JIANG S Y, et al. Up-regulation of the receptor for advanced glycation end products (RAGE) in esophageal cancer and down-regulation in lung cancer and their relationship to clinicopathological features[J]. Am J Clin Pathol, 2008, 39(10):661-667.
 
【13】谢文熙, 吴心愿. HMGB1/RAGE蛋白在食管鳞癌中的表达及临床意义[J]. 中国实用医药, 2010, 6(4):6-8.
 
【14】LECLERC E, HEIZMANN C W, VETTER S W. RAGE and S100 protein transcription levels are highly variable in human melanoma tumors and cells[J]. Gen Physiol Biophys, 2009, 28:F65-75.
 
【15】黄家军, 王斌全, 苏炳泽, 等. 鼻咽癌组织RAGE表达与微血管发生的相关性研究[J]. 中国现代药物应用, 2010, 4(3):2-4.
 
【16】KUNIYASU H, OUE N, WAKIKAWA A, et al. Expression of receptors for advanced glycation end-products (RAGE) is closely associated with the invasive and metastatic activity of gastric cancer[J]. J Pathol, 2002, 196(2):163-170.
 
【17】TAKADA M, HIRATA K, AJIKI T, et al. Expression of receptor for advanced glycation end products (RAGE) and MMP-9 in human pancreatic cancer cells[J]. Hepatogastroenterology, 2004, 51(58):928-930.
 
【18】ISHIGURO H, NAKAIGAWA N, MIYOSHI Y, et al. Receptor for advanced glycation end products (RAGE) and its ligand, amphoterin are overexpressed and associated with prostate cancer development[J]. Prostate, 2005, 64(1):92-100.
 
【19】SORCI G, RIUZZI F, ARCURI C, et al. Amphoterin stimulates myogenesis and counteracts the antimyogenic factors basic fibroblast growth factor and S100B via RAGE binding[J]. Mol Cell Biol, 2004, 24(11):4880-4894.
 
【20】JING R, CUI M, WANG J, et al. Receptor for advanced glycation end products (RAGE) solubleform (sRAGE):a new biomarker for lung cancer[J]. Neoplasma, 2010, 57(1):55-61.
 
【21】KOBAYASHI S, KUBO H, SUZUKI T, et al. Endogenous secretory receptor for advanced glycation end products in non-small cell lung carcinoma[J]. Am J Respir Crit Care Med. 2007, 175(2):184-189.
 
【22】RIUZZI F, SORCI G, DONATO R. RAGE expression in rhabdomyosarcoma cells results in myogenic differentiation and reduced proliferation, migration, invasiveness, and tumor growth[J]. Am J Pathol, 2007, 171(3):947-961.
 
【23】MUKHERJEE T K, MUKHOPADHYAY S, HOIDAL J R. Implication of receptor for advanced glycation end products (RAGE) in pulmonary health and pathophysiology[J]. Respir Physiol Neurobiol, 2008, 162(3):210-215.
 
【24】KANG R, TANG D, SCHAPIRO N E, et al. The receptor for advanced glycation end products (RAGE) sustains autophagy and limits apoptosis, promoting pancreatic tumor cell survival[J]. Cell Death Differ, 2010, 17(4):666-676.
 
【25】TANG D, LOZW M T, ZEH H J, et al. The redox protein HMGB1 regulates cell death and survival in cancer treatment[J]. Autophagy, 2010, 6(8):1181-1183.
 
【26】HOFFMANN S, FRIEDRICHS U, EICHLER W, et al. Advanced glycation end products induce choroidal endothelial cell proliferation, matrix metalloproteinase-2 and VEGF upregulation in vitro[J]. Graefes Arch Clin Exp Ophthalmol, 2002, 240(12):996-1002.
 
【27】DING Y T, KUMAR S, YU D C. The role of endothelial pro-genitor cells in tumour vasculogenesis[J]. Pathobiology, 2008, 75(5):265-273.
 
【28】YANG L, DEBUSK LM, FUKUDA K, et al. Expansion of myeloid immune suppressor Gr+CD11b+ cells in tumor-bearing host directly promotes tumor angiogenesis[J]. Cancer Cell, 2004, 6(4):409-421.
 
【29】ZHANG C L, SHU M G, QI H W, et al. Inhibition of tumor angiogenesis by HMGB1 A box peptide[J]. Med Hypotheses, 2008, 70(2):343-345.
 
【30】HERMANI A, DE SERVI B, MEDUNJANIN S, et al. S100A8 and S100A9 activate MAP kinase and NF-kappaB signaling pathways and trigger translocation of RAGE in human prostate cancer cells[J]. Exp Cell Res, 2006, 312(2):184-197.
 
【31】BARTLIN B, DEMLING N, SILBER R E, et al. Proliferative stimulus of lung fibroblasts on lung cancer cells is impaired by the receptor for advanced glycation end-products[J]. Am J Respir Cell Mol Biol, 2006, 34(1):83-91.
 
【32】RIUZZI F, SORCI G, DONATO R. The amphoterin (HMGB1)/receptor for advanced glycation end products (RAGE) pair modulates myoblast proliferation, apoptosis, adhesiveness, migration, and invasiveness. Functional inactivation of RAGE in L6 myoblasts in tumor formation in vivo[J]. J Biol Chem, 2006, 281(12):8242-8253.
 
【33】MANTOVANI A, ALLAVENA P, SICA A, et al. Cancer-related inflammation[J]. Nature, 2008, 454(7203):436-444.
 
【34】ROJAS A, FIGUEROA H, MORALES E. Fueling inflammation at tumor microenvironment:the role of multiligand/RAGE axis[J]. Carcinogenesis, 2010, 31(3):334-341.
 
【35】孙新平, 马春燕, 焦玉莲, 等. shRNA沉默RAGE基因表达对前列腺癌细胞增殖的抑制作用[J]. 肿瘤, 2010, 30(3):199-204.
 
【36】TAN A L, FORBES J M, COOPER M E. AGE, RAGE, and ROS in diabetic nephropathy[J]. Semin Nephrol, 2007, 27(2):130-143.
 
【37】BIERHAUS A, HUMPERT P M, STERN D M, et al. Advanced glycation end product receptor-mediated cellular dysfunction[J]. Ann N Y Acad Sci, 2005, 1043:676-680.
 
【38】BIERHAUS A, HUMPERT P M, MORCOS M, et al. Understanding RAGE, the receptor for advanced glycation end products[J]. J Mol Med, 2005, 83(11):876-886.
 
相关信息
   标题 相关频次
 抑制肿瘤转移的新策略——靶向肿瘤细胞的外渗过程
 8
 川芎嗪抑制缺氧诱导的乳腺癌MDA-MB-435S细胞的侵袭及迁移
 6
 肿瘤血管正常化与肿瘤治疗
 6
 肿瘤转移新靶点HOTAIR的研究进展
 6
 转录因子叉头框Q1与肿瘤相关性的研究进展
 6
 SEPT 9基因与恶性肿瘤关系的研究进展
 4
 TFPI-2基因表达变化与声门上喉癌侵袭转移及预后的相关性研究
 4
 CD26/DPPⅣ与肿瘤相关的研究进展
 4
 Claudin-7、β-catenin和MT1-mmp在乳腺癌中的表达及意义
 4
 CTHRC1基因在人肝癌中高表达并促进MHCC97L肝癌细胞的转移
 4
 Hedgehog信号通路与肿瘤侵袭转移作用的研究进展
 4
 MRP-1/CD9与高转移人乳腺癌MDA-MB-231细胞恶性行为相关性的体外研究
 4
 MTA1蛋白在乳腺癌浸润与转移中作用的研究
 4
 NK细胞在肿瘤免疫治疗中的研究进展展
 4
 PGC-1α与肿瘤代谢关系的研究进展
 4
 PI3K/Akt/mTOR通路抑制剂依维莫司治疗晚期乳腺癌的
 4
 长链非编码RNA在肿瘤转移中的调控作用
 4
 常见消化道恶性肿瘤患者血清VEGF表达水平及其临床意义
 4
 大黄素诱导裸鼠体内白血病K562细胞凋亡过程中PI3K/AKT通路相关分子表达的变化
 4
 电压门控性钠通道与肿瘤的研究进展
 4
 高尔基体α-甘露糖苷酶Ⅱ、E-cadherin和α-catenin在卵巢上皮肿瘤组织和不同转移能力的卵巢癌细胞中的表达
 4
 核干细胞因子与肿瘤的研究进展
 4
 激肽释放酶相关肽酶家族与卵巢癌的研究进展
 4
 辣椒素抗肿瘤作用研究进展
 4
 利用GEO公共数据集分析CHAF1A在肿瘤中的表达及临床意义
 4
 临床前癌症模型的研究进展
 4
 脾源性酪氨酸激酶抗肿瘤侵袭迁移的作用机制
 4
 趋化因子CCL20与恶性肿瘤之间的关系
 4
 缺氧微环境在肿瘤进展中的作用
 4
 瞬时受体通道TRPM8及其对前列腺癌的影响
 4

  热点专题


关于我们  |   联系我们  |   广告投放  |   《肿瘤》杂志社版权所有 《肿瘤》杂志社   © 中国 上海 2014.3
沪ICP备15036656号-2